Global bone cancer incidence and death rate analysis at 40 years

Abstract Background Bone cancer exhibits significant global disparities in incidence and mortality. Understanding these trends is essential for identifying high-risk populations and informing targeted interventions. Methods Using data from the Global Burden of Disease Study 2021 (GBD 2021) and the C...

Full description

Saved in:
Bibliographic Details
Main Authors: Peiran Liu, Hang Lv, Yongji Li, Zelin Liu, Xiangjun Yang, Hai Hu
Format: Article
Language:English
Published: Springer 2025-06-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-02917-1
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849335748128407552
author Peiran Liu
Hang Lv
Yongji Li
Zelin Liu
Xiangjun Yang
Hai Hu
author_facet Peiran Liu
Hang Lv
Yongji Li
Zelin Liu
Xiangjun Yang
Hai Hu
author_sort Peiran Liu
collection DOAJ
description Abstract Background Bone cancer exhibits significant global disparities in incidence and mortality. Understanding these trends is essential for identifying high-risk populations and informing targeted interventions. Methods Using data from the Global Burden of Disease Study 2021 (GBD 2021) and the Cancer Incidence in Five Continents (CI5) database, this study analyzed bone cancer incidence (1993–2017) and mortality (1980–2021) trends. Age-standardized incidence rates (ASRs, per 100,000) and mortality rates were assessed across regions, countries, income levels, and health systems, focusing on gender differences and healthcare capacity. Results Bone cancer ASRs (1993–2017) ranged from 0.53 to 2.72 for females (China: Yunmeng County, 2.72 [2.16–3.28]) and 0.90–4.28 for males (China: Xiangfu District, 4.28 [3.25–5.31], p < 0.0001), with minimal rates near zero like Brazil: Jau and USA: Hawaii Chinese. Mortality rates (1980–2021) peaked in Eastern Europe and Central Asia, with male rates up to 2.90 (Romania, 2.90 [1.89–3.90], 1980) and female rates up to 2.34 (Greece, 2.34 [2.11–2.58], 1980), while high-income regions like Western Europe declined to 0.84 (males, 0.84 [0.76–0.90], 2021). By 2021, Upper Middle-Income countries (1.26 [0.85–1.62] for males) and Basic Health Systems (1.27 [0.85–1.59] for males) showed rising mortality, surpassing Advanced Health Systems (0.76 [0.71–0.81] for males), reflecting healthcare disparities. Thailand (males, 2.06 [1.18–3.01], 2021) and China saw increasing rates, unlike stable low rates in the USA (males, 0.71 [0.67–0.74], 2021). Conclusions Bone cancer incidence and mortality are heavily influenced by healthcare system capacity and socioeconomic factors.
format Article
id doaj-art-2252c7ffeb6e4d49b4ecce78d4c18238
institution Kabale University
issn 2730-6011
language English
publishDate 2025-06-01
publisher Springer
record_format Article
series Discover Oncology
spelling doaj-art-2252c7ffeb6e4d49b4ecce78d4c182382025-08-20T03:45:11ZengSpringerDiscover Oncology2730-60112025-06-0116112410.1007/s12672-025-02917-1Global bone cancer incidence and death rate analysis at 40 yearsPeiran Liu0Hang Lv1Yongji Li2Zelin Liu3Xiangjun Yang4Hai Hu5Department of Bone Injuries, Hanan Branch of the Second Affiliated Hospital of Heilongjiang University of Traditional Chinese medicineDepartment of Bone Injuries, Hanan Branch of the Second Affiliated Hospital of Heilongjiang University of Traditional Chinese medicineDepartment of Bone Injuries, Hanan Branch of the Second Affiliated Hospital of Heilongjiang University of Traditional Chinese medicineDepartment of Medical Services Division, The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese medicineDepartment of Bone Injuries, Hanan Branch of the Second Affiliated Hospital of Heilongjiang University of Traditional Chinese medicineDepartment of Bone Injuries, Hanan Branch of the Second Affiliated Hospital of Heilongjiang University of Traditional Chinese medicineAbstract Background Bone cancer exhibits significant global disparities in incidence and mortality. Understanding these trends is essential for identifying high-risk populations and informing targeted interventions. Methods Using data from the Global Burden of Disease Study 2021 (GBD 2021) and the Cancer Incidence in Five Continents (CI5) database, this study analyzed bone cancer incidence (1993–2017) and mortality (1980–2021) trends. Age-standardized incidence rates (ASRs, per 100,000) and mortality rates were assessed across regions, countries, income levels, and health systems, focusing on gender differences and healthcare capacity. Results Bone cancer ASRs (1993–2017) ranged from 0.53 to 2.72 for females (China: Yunmeng County, 2.72 [2.16–3.28]) and 0.90–4.28 for males (China: Xiangfu District, 4.28 [3.25–5.31], p < 0.0001), with minimal rates near zero like Brazil: Jau and USA: Hawaii Chinese. Mortality rates (1980–2021) peaked in Eastern Europe and Central Asia, with male rates up to 2.90 (Romania, 2.90 [1.89–3.90], 1980) and female rates up to 2.34 (Greece, 2.34 [2.11–2.58], 1980), while high-income regions like Western Europe declined to 0.84 (males, 0.84 [0.76–0.90], 2021). By 2021, Upper Middle-Income countries (1.26 [0.85–1.62] for males) and Basic Health Systems (1.27 [0.85–1.59] for males) showed rising mortality, surpassing Advanced Health Systems (0.76 [0.71–0.81] for males), reflecting healthcare disparities. Thailand (males, 2.06 [1.18–3.01], 2021) and China saw increasing rates, unlike stable low rates in the USA (males, 0.71 [0.67–0.74], 2021). Conclusions Bone cancer incidence and mortality are heavily influenced by healthcare system capacity and socioeconomic factors.https://doi.org/10.1007/s12672-025-02917-1ChondrosarcomaGlobal burdenHealthcare infrastructureOsteosarcomaRegional health disparities
spellingShingle Peiran Liu
Hang Lv
Yongji Li
Zelin Liu
Xiangjun Yang
Hai Hu
Global bone cancer incidence and death rate analysis at 40 years
Discover Oncology
Chondrosarcoma
Global burden
Healthcare infrastructure
Osteosarcoma
Regional health disparities
title Global bone cancer incidence and death rate analysis at 40 years
title_full Global bone cancer incidence and death rate analysis at 40 years
title_fullStr Global bone cancer incidence and death rate analysis at 40 years
title_full_unstemmed Global bone cancer incidence and death rate analysis at 40 years
title_short Global bone cancer incidence and death rate analysis at 40 years
title_sort global bone cancer incidence and death rate analysis at 40 years
topic Chondrosarcoma
Global burden
Healthcare infrastructure
Osteosarcoma
Regional health disparities
url https://doi.org/10.1007/s12672-025-02917-1
work_keys_str_mv AT peiranliu globalbonecancerincidenceanddeathrateanalysisat40years
AT hanglv globalbonecancerincidenceanddeathrateanalysisat40years
AT yongjili globalbonecancerincidenceanddeathrateanalysisat40years
AT zelinliu globalbonecancerincidenceanddeathrateanalysisat40years
AT xiangjunyang globalbonecancerincidenceanddeathrateanalysisat40years
AT haihu globalbonecancerincidenceanddeathrateanalysisat40years